ERNA vs MAS · P/E 0.0, rev $582.0K vs P/E 18, rev $7.83B
Eterna Therapeutics Inc (ERNA) versus Masco Corporation (MAS) — a side-by-side from cached financials, not a winner call.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Masco Corporation (MAS) is a building products & equipment company listed on US.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Latest reported MAS revenue for 2024-12-31 was $7.83B. Net income was $874.0M. Revenue was down 1.7% from 2023-12-31 to 2024-12-31. MAS currently screens at market cap $14.00B and trailing P/E 18.1.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0. MAS currently screens at market cap $14.00B and trailing P/E 18.1.
Not investment advice. Open the ERNA and MAS stock pages for the full models.
Not investment advice.